Graphene plays an etiologic role for the new edge drug designing in the area of therapeutic management of myriads of diseases. Several researchers have experimentally validated the use of graphene and its derivative either in chemical form or in their nano-form to provide a longer and better life to the patients suffering from cancer, diabetes, etc. In this review, we have tried to focus on the literature to understand molecular docking-based role of graphene as an anti-cancer and anti-diabetic therapeutic tool which is very pertinent in the extensive arena of pharmacology, from pharmacovigilance to pharmacodynamics and kinetics, that ameliorates and concords with the modern scientific approaches of disease management.

Neurodegeneration is the progressive loss of structure or function of neurons, which may ultimately involve cell death. The most common neurodegenerative disorder in the brain happens with Alzheimer’s disease (AD) which is the most common cause of dementia. It ultimately leads to neuronal death, thereby impairing the normal functionality of the central or peripheral nervous system. The onset and prevalence of AD involve heterogeneous etiology, either in terms of genetic predisposition, neuro-metabolomic malfunctioning, or lifestyle. The worldwide relevancies are estimated to be over 45 million people. The rapid increase in AD has led to a concomitant increase in the research work, directed towards the discovery of a lucrative cure for AD. The neuropathology of AD comprises the deficiency in the availability of neurotransmitters and important neurotrophic factors in the brain, extracellular beta-amyloid plaque depositions, and intracellular neurofibrillary tangles of hyperphosphorylated tau protein. Current pharmaceutical interventions utilizing synthetic drugs have manifested resistance and toxicity problems. This has led to the quest for new pharmacotherapeutic candidates naturally prevalent in phyto chemicals. This review aims to provide an elaborative description of promising phyto component entities having activities against various potential AD targets. Therefore, naturopathy may combine with synthetic chemotherapeutics to longer the survival of the patients.